41 related articles for article (PubMed ID: 36239795)
1. Non-Guideline-concordant Treatment of Testicular Cancer Is Associated With Reduced Relapse-free Survival.
Paffenholz P; Heidegger IM; Kuhr K; Loosen SH; Pfister D; Heidenreich A
Clin Genitourin Cancer; 2017 Sep; ():. PubMed ID: 28964691
[TBL] [Abstract][Full Text] [Related]
2. S2k-Guideline for Teledermatology.
Augustin M; Djamei V; Elsner P; Gass S; Hofmann-Wellenhof R; Kaminski K; Kirsten N; Nast A; Navarini-Meury A; Otten M; Salzer B; von Kiedrowski R; Zink A; Strömer K
J Dtsch Dermatol Ges; 2021 Dec; ():. PubMed ID: 34932269
[No Abstract] [Full Text] [Related]
3. Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study.
Pelzer F; Tröger W; Reif M; Schönberg S; Martin DD; Müller C; Utz-Billing I; Kühn T; Baumgartner S; Kiechle M; Paepke D
Breast Cancer; 2024 Jan; 31(1):124-134. PubMed ID: 37966690
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy for stage I endometrial cancer.
Kong A; Johnson N; Kitchener HC; Lawrie TA
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003916. PubMed ID: 22513918
[TBL] [Abstract][Full Text] [Related]
5. Guideline concordant therapy improves survival in high-grade endometrial cancer patients.
Scharl S; Sprötge T; Gerken M; Scharl A; Ortmann O; Kölbl O; Klinkhammer-Schalke M; Papathemelis T
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4761-4769. PubMed ID: 36239795
[TBL] [Abstract][Full Text] [Related]
6. Does post-operative radiochemotherapy improve survival in high-grade endometrial cancer patients? Results of a population-based cohort analysis of a cancer registry.
Scharl S; Papathemelis T; Kronberger K; Gerken M; Scharl A; Kölbl O; Klinkhammer-Schalke M
Arch Gynecol Obstet; 2018 May; 297(5):1245-1253. PubMed ID: 29417286
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Prognostic Factors and Adjuvant Radiotherapy on Survival in Patients with High-Grade Early-Stage Endometrial Cancer: A Retrospective Clinical Study.
Yilmaz E; Gurocak S; Melekoglu R; Koleli I; Faydali S; Temelli O; Yar T
Med Sci Monit; 2019 Apr; 25():2811-2818. PubMed ID: 30992424
[TBL] [Abstract][Full Text] [Related]
8. Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma.
Elshaikh MA; Vance S; Suri JS; Mahan M; Munkarah A
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):351-6. PubMed ID: 24411608
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for advanced endometrial cancer.
Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
[TBL] [Abstract][Full Text] [Related]
10. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
11. Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer.
Dholakia J; Llamocca E; Quick A; Salani R; Felix AS
Gynecol Oncol; 2020 Jun; 157(3):716-722. PubMed ID: 32217002
[TBL] [Abstract][Full Text] [Related]
12. Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients.
Taubenhansl C; Ortmann O; Gerken M; Inwald EC; Klinkhammer-Schalke M
Arch Gynecol Obstet; 2020 Feb; 301(2):573-583. PubMed ID: 31749031
[TBL] [Abstract][Full Text] [Related]
13. Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.
Felix AS; McLaughlin EM; Caan BJ; Cohn DE; Anderson GL; Paskett ED
Int J Cancer; 2020 Jul; 147(2):404-412. PubMed ID: 31618444
[TBL] [Abstract][Full Text] [Related]
14. Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.
Randall ME; Filiaci V; McMeekin DS; von Gruenigen V; Huang H; Yashar CM; Mannel RS; Kim JW; Salani R; DiSilvestro PA; Burke JJ; Rutherford T; Spirtos NM; Terada K; Anderson PR; Brewster WR; Small W; Aghajanian CA; Miller DS
J Clin Oncol; 2019 Jul; 37(21):1810-1818. PubMed ID: 30995174
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
